Proposed New Prevention or Treatment

• Vaccines against herpes have been developed but are still considered experimental drugs. Thus, more powerful vaccine should be developed to make our body more resistant to the HSV-2.
  
• We should always maintain a good personal hygiene to reduce the risk.
  
• Washing solution that applies to the genital area, which tends to kill the herpes virus, can be developed too.
  
• Since the nucleoside analogs caused genetic material defect and mutation in the next generation of HSV-2 in an infected individual, a new drug that prevent replication of the virus could be developed to inhibit the virus reproduce in the human body.
  
• Attachment proteins are found on viruses. Since the interaction of the surface lipoproteins or glycoprotein (known as ligand) with host receptor can determine the specificity for host cells, the structural changes or blockage of the ligands or its receptor can be taken into consideration to design a drug to inhibit integration of ligands with host cells, and thus prevent or reduce the genital infection.

References:
1. Health Beat, January 2008: ILLINOIS DEPARTMENT OF PUBLIC HEALTH, “Genital Herpes”. Internet: http://www.idph.state.il.us/public/hb/hbherpes.htm
2. Australian Herpes Management Forum, 1997-2007: “Genital Herpes”. Internet: http://www.ahmf.com.au/herpes/default.htm
3. MedLine Plus Medical Encyclopedia, March 2008: “Genital Herpes”. Internet: http://www.nlm.nih.gov/medlineplus/ency/article/000857.htm

Comments and inquiries are always welcome.

Prepared by Wong Li Chin 1071113696